Blog News Our authors About Blog Useful links Contacts us
Eng Rus Ukr
Login
All posts

Mariia Cherska, Khrystyna Kukharchuk, Olha Haiova

21.05.2021
2 Minutes Read Укр, Рус, Eng
Share Post

Options for corrections of the post-covid syndrome in routine clinical practice

Post updated: July 19

The present review article gives the results of source analysis regarding recommendations to detect, diagnose and treat the patients having post-COVID syndrome. 

NICE (the National Institute for Clinical Excellence, 2020) Guideline defines post-COVID syndrome as features and symptoms which develop either during or after infection corresponding to COVID-19. The products influencing endothelium and CNS play an important role in treating post-COVID syndrome. 

The following products of the company Nikopharm are available in the Ukrainian market: Nikomex (ethylmethylhydroxylpyridine succinate), Mildrocard (meldonium) and Pharmaxon (cyticoline); their clinical characteristics may help in routine clinical practice in order to ease the post-COVID syndrome caused by increased activity of the sympathetic nervous system and endothelial dysfunction: fatigue, tachycardia, asthenia, cognitive and psycho-emotional disorders, insomnia etc.

See the full text below.

#постковидный синдром
#эндотелиальная дисфункция
#post-covid syndrome
#endothelial dysfunction
Можливості корекції постковідного синдрому в рутинній клінічній практиці
pdf


Views: 1258

Recent Posts
See all
Забитые сосуды головы
Clogged vessels of the head. Cardiologist's advice

197
PRO КАРДІОПРОФІЛАКТИКУ: частина 2
Workshop CARDIO PREVENTION - important knowledge for every doctor

250
4 опасных продукта для сердца
4 dangerous products for the heart

265

Share a post

Close X

Publication subscription form

A confirmation code has been sent to your email.

Thank you! You have successfully subscribed to new publications.

Verification code does not match, please enter the last received code

Email:
Code:
Close X
Subscribe

©2020-2023 TechnoDreams